IN DEPTH

Neglected tropical diseases: non-profits lead the way as private sectors lags

CMO Moves: Regulatory catalysts for drug manufacturing

R&D

Genomic projects exploit scale as clinical applications play catch-up

New studies on gene signatures and chromosomal instability using samples from large databases add insight to their clinical applicability.

Rare Disorders

Tracing the rise of orphan drug designations over almost 40 years

R&D

How much does it hurt-measuring pain in clinical trials

Neglected tropical diseases: non-profits lead the way as private sectors lags

CMO Moves: Regulatory catalysts for drug manufacturing

07/25/2022 08:30:28
  • Home | Genomic projects exploit scale
  • In this issue
  • Contents
  • Mimotopes Company Insight
  • Mimotopes
  • Briefing
  • Industry news
  • The pharma industry briefing
  • Owen Mumford Company Insight
  • Owen Mumford
  • Comment
  • Disappointing results signal setbacks for Alzheimer’s treatments
  • Heart failure: charting the clinical trial landscape in the past decade
  • Russia’s focus on domestic pharma production could shield it from sanctions
  • Delayed EMA approval: improved safety or lack of access to therapeutics?
  • CMOs and US Government invest in continuous manufacturing
  • Baxter
  • CSafe Global
  • Nipro
  • In Depth
  • Genomic projects exploit scale as clinical applications play catch-up
  • Tracing the rise of orphan drug designations over almost 40 years
  • How much does it hurt—measuring pain in clinical trials
  • Neglected tropical diseases: non-profits lead the way as private sectors lags
  • CMO Moves: Regulatory catalysts for drug manufacturing-July
  • Pfeiffer Vacuum
  • Biolife Solutions
  • In Data
  • Supply chain & logistics innovation among pharma companies
  • Hiring boom in pharmaceutical industry IoT roles
  • Regenerative medicine deals decreased in the pharma industry
  • Digitalization jobs in the pharmaceutical industry
  • Events
  • Next issue